The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,673,908 in first-year total cost, median $123,388.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (O1)]13
Most frequent institutions
- SLOAN-KETTERING INST CAN RESEARCH2
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL2
- CEDARS-SINAI MEDICAL CENTER1
- DANA-FARBER CANCER INST1
- HARVARD SCHOOL OF PUBLIC HEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy Monitoring1K99CA256353-01 | KO, JINA | MASSACHUSETTS GENERAL HOSPITAL, MA | $178,080 | ZCA1 |
| 2021 | Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations1K99CA256519-01 | PENG, PEI-CHEN | CEDARS-SINAI MEDICAL CENTER, CA | $173,048 | ZCA1 |
| 2021 | Do Tumor-Immune Interactions Prime Systemic Tolerance of Triple-Negative Breast Cancer Brain Metastases?1K99CA256522-01 | UMEH GARCIA, MAXINE CHIDINMA | STANFORD UNIVERSITY, CA | $162,617 | ZCA1 |
| 2021 | Investigating the Role of Radiation-induced Cell Death in Innate Lymphoid Cell Activation within Unique Tumor Microenvironments1K99CA256526-01 | MCGEE, HEATHER MICHELLE | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | $136,944 | ZCA1 |
| 2021 | Integrative Prediction of Therapeutic Response in T-cell Lymphoma by Omic and Spatial Modeling1K99CA256497-01 | NIRMAL, AJIT JOHNSON | DANA-FARBER CANCER INST, MA | $136,080 | ZCA1 |
| 2021 | Improving CAR T cell therapy for brain tumors using immune competent models1K99CA256262-01 | HAYDAR, DALIA | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $125,023 | ZCA1 |
| 2021 | Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma Survivors1K99CA256356-01 | WILLIAMS, ANNALYNN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $123,388 | ZCA1 |
| 2021 | Integrating epidemiologic, clinical, genomic and metabolomic profiles to predict pancreatic cancer risk in a multiethnic population1K99CA256525-01 | HUANG, BRIAN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $119,917 | ZCA1 |
| 2021 | Mechanistically Dissecting Glycolysis Regulation by Lactate and Its Therapeutic Potential in Cancer1K99CA256505-01 | CAI, XIN | SLOAN-KETTERING INST CAN RESEARCH, NY | $113,359 | ZCA1 |
| 2021 | Multilevel investigation of uncertain and reclassified genomic variants in clinical oncology1K99CA256216-01 | MAKHNOON, SUKH | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $107,869 | ZCA1 |
| 2021 | Methods for Mendelian randomization and mediation analysis using integrative genetic and genomic data for breast cancer1K99CA256513-01 | ZHANG, HAOYU | HARVARD SCHOOL OF PUBLIC HEALTH, MA | $100,023 | ZCA1 |
| 2021 | Single cell quantification of genomic instability in cancer as a determinant of therapeutic response1K99CA256508-01 | WILLIAMS, MARC | SLOAN-KETTERING INST CAN RESEARCH, NY | $99,798 | ZCA1 |
| 2021 | Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer1K99CA256350-01 | MUDUMBI, KRISHNA CHAITANYA | YALE UNIVERSITY, CT | $97,762 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.